Applied Therapeutics, Inc. (APLT)
APLT moved a median of -0.33% 30 minutes after news, and -1.11% by the close. How APLT actually reacts to news — the realized, point-in-time move the market made, measured across 1,199 labeled events over the last three years with zero look-ahead.
APLT’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.20% | 43% | 1,174 |
| 30-min | -0.33% | 45% | 1,175 |
| 60-min | -0.47% | 45% | 1,175 |
| to close | -1.11% | 42% | 1,173 |
| Middle 50% of APLT reactions | -2.92% to +1.71% |
|---|---|
| Median reaction (30-min) | -0.33% |
| Measured reactions | 1,199 |
Half of all Applied Therapeutics, Inc. news events land between -2.92% and +1.71% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How APLT reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades | 14 | -0.50% | 21% | +0.57% |
| Rating reiterations | 17 | +0.60% | 53% | -0.48% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 4 further classes were observed with fewer than 10 measured events and are not published. See how APLT ranks against every other measured name →
That’s how APLT usually reacts — get an email when it moves on news →Email me when APLT moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to APLT's baseline. Nothing else.
Recent APLT events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 15-12G Applied Therapeutics, | SEC filing · Form 15-12G | SEC EDGAR | — | — | |
| Form EFFECT Applied Therapeutics, | SEC filing · Form EFFECT | SEC EDGAR | — | — | |
| Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics | Press release | Business Wire | — | — | |
| Form 8-K Applied Therapeutics, For: Feb 03 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form POS AM Applied Therapeutics, | SEC filing · Form POS | SEC EDGAR | — | — | |
| Form S-8 POS Applied Therapeutics, | SEC filing · Form S-8 | SEC EDGAR | — | — | |
| Applied Therapeutics Shares Letter to Stockholders Recommending Tender of Shares Following Offer Expiration Extension | Press release | GlobeNewswire | +1.76% | +4.95% | |
| Halper Sadeh LLC Encourages QIPT, FITB, GBIO, APLT Shareholders to Contact the Firm to Discuss Their Rights | Press release | PR Newswire | +0.80% | +7.19% | |
| APLT Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Applied Therapeutics, Inc. is Fair to Shareholders | Press release | Business Wire | -11.96% | -8.29% | |
| Form 8-K Applied Therapeutics, For: Dec 11 | SEC filing · Form 8-K | SEC EDGAR | -11.96% | -8.29% | |
| Cycle Pharmaceuticals to Acquire Applied Therapeutics | Press release | GlobeNewswire | -11.96% | -8.29% | |
| Applied Therapeutics Announces Corporate Updates | Press release | GlobeNewswire | +2.13% | +3.92% | |
| Form 8-K Applied Therapeutics, For: Nov 20 | SEC filing · Form 8-K | SEC EDGAR | +2.13% | +3.92% | |
| Applied Therapeutics Reports Third Quarter 2025 Financial Results | Press release | GlobeNewswire | +1.63% | — | |
| Form 10-Q Applied Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +1.63% | — | |
| Form 8-K Applied Therapeutics, For: Nov 09 | SEC filing · Form 8-K | SEC EDGAR | +1.63% | — | |
| Halper Sadeh LLC Encourages Applied Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights | Press release | Business Wire | +0.41% | +5.69% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.02% | +20.00% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.40% | +5.00% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Applied Therapeutics, Inc. (APLT) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | +0.40% | +5.00% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +2.55% | +2.00% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Applied Therapeutics, Inc. (APLT) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | +2.55% | +2.00% | |
| Applied Therapeutics, Inc. (APLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | -0.03% | +1.92% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.11% | +1.93% | |
| Applied Therapeutics Provides Update Following Meeting with FDA | Press release | GlobeNewswire | -9.24% | -2.56% | |
| Applied Therapeutics, Inc. (APLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | -0.38% | +18.71% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.38% | +18.71% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | -2.67% | +5.73% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Applied Therapeutics, Inc. (APLT) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | +0.70% | +4.26% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Applied Therapeutics, Inc. (APLT) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | -0.59% | +0.89% | |
| Applied Therapeutics, Inc. (APLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +1.07% | -1.07% | |
| Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); LuxUrban Hotels Inc. (OTC: LUXH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims o | Press release | GlobeNewswire | +1.49% | -2.35% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Applied Therapeutics, Inc. (APLT) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | -0.43% | -1.17% | |
| Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Lantheus Holdings, Inc. (NASDAQ: LNTH); Savara Inc. (NASDAQ: SVRA); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your | Press release | GlobeNewswire | -1.67% | -2.99% | |
| Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf | Press release | GlobeNewswire | -1.47% | +1.81% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.00% | +0.18% | |
| Form 8-K Applied Therapeutics, For: Aug 29 | SEC filing · Form 8-K | SEC EDGAR | -0.20% | +2.18% | |
| Form 8-K Applied Therapeutics, For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | -0.58% | +8.86% | |
| Applied Therapeutics Reports Second Quarter 2025 Financial Results | Press release | GlobeNewswire | -0.58% | +8.86% | |
| Form 10-Q Applied Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.58% | +8.86% | |
| Form 8-K Applied Therapeutics, For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | -0.58% | +8.86% | |
| Form 8-K Applied Therapeutics, For: Aug 11 | SEC filing · Form 8-K | SEC EDGAR | -0.02% | — | |
| Applied Therapeutics Announces Key Leadership Appointments | Press release | GlobeNewswire | +2.94% | +3.09% | |
| Form 8-K Applied Therapeutics, For: Jun 15 | SEC filing · Form 8-K | SEC EDGAR | +2.94% | +3.09% | |
| Form 8-K Applied Therapeutics, For: Jun 09 | SEC filing · Form 8-K | SEC EDGAR | +1.07% | +0.00% | |
| Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting | Press release | GlobeNewswire | -5.28% | -21.40% | |
| Form 10-Q Applied Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +2.23% | +13.39% | |
| Applied Therapeutics Reports First Quarter 2025 Financial Results | Press release | GlobeNewswire | +2.23% | +13.39% | |
| Form 8-K Applied Therapeutics, For: May 13 | SEC filing · Form 8-K | SEC EDGAR | +2.23% | +13.39% | |
| Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting | Press release | GlobeNewswire | +2.38% | +10.14% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the APLT section they belong to.
Where else APLT is measured.
APLT earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Applied Therapeutics, Inc.'s median reaction calculated?
Every labeled APLT news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 1,199 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 45% of APLT's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does APLT's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.